Mechanisms of Endothelial Dysfunction, Injury, and Death

被引:198
作者
Pober, Jordan S. [1 ,2 ,3 ]
Min, Wang [3 ]
Bradley, John R. [4 ]
机构
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[4] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QR, England
基金
美国国家卫生研究院;
关键词
apoptosis; endothelial activation; environmental stress; death receptors; lymphocytes; reactive oxygen species; ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; ANTIENDOTHELIAL CELL ANTIBODIES; OXIDATIVE STRESS; CYTOPLASMIC TRANSLOCATION; ASK1-MEDIATED APOPTOSIS; INDUCED DESUMOYLATION; PROGENITOR CELLS; DEFINED INJURY; T-CELLS;
D O I
10.1146/annurev.pathol.4.110807.092155
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vascular endothelial cells normally perform several key homeostatic functions such as keeping blood fluid, regulating blood flow, regulating macromolecule and fluid exchange with the tissues, preventing leukocyte activation, and aiding in immune surveillance for pathogens. Injury or cell death impairs or prevents conduct of these activities, resulting in dysfunction. Most endothelial cell death is apoptotic, involving activation of caspases, but nonapoptotic death responses also have been described. Stimuli that can cause endothelial injury or death include environmental stresses such as oxidative stress, endoplasmic reticulum stress, metabolic stress, and genotoxic stress, as well as Pathways of injury mediated by the innate and adaptive immune systems. Pathways of immune-mediated death include those activated by death receptors as well as those activated by cytolytic granules and reactive oxygen species. The biochemical pathways activated by these injurious stimuli are described herein and will serve as a basis for future development of endothelial protective therapies.
引用
收藏
页码:71 / 95
页数:25
相关论文
共 97 条
[1]   Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1 [J].
Abe, H ;
Yamada, N ;
Kamata, K ;
Kuwaki, T ;
Shimada, M ;
Osuga, J ;
Shionoiri, F ;
Yahagi, N ;
Kadowaki, T ;
Tamemoto, H ;
Ishibashi, S ;
Yazaki, Y ;
Makuuchi, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1784-1788
[2]   TNFR1-and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury [J].
Al-Lamki, RS ;
Wang, J ;
Vandenabeele, P ;
Bradley, JA ;
Thiru, S ;
Luo, DH ;
Min, W ;
Pober, JS ;
Bradley, JR .
FASEB JOURNAL, 2005, 19 (12) :1637-1645
[3]   Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1 [J].
Alavi, Alireza S. ;
Acevedo, Lisette ;
Min, Wang ;
Cheresh, David A. .
CANCER RESEARCH, 2007, 67 (06) :2766-2772
[4]  
Arnout J., 2006, V176, P1
[5]   Mitochondria, oxidants, and aging [J].
Balaban, RS ;
Nemoto, S ;
Finkel, T .
CELL, 2005, 120 (04) :483-495
[6]   Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis [J].
Bazzoni, G ;
Dejana, E .
PHYSIOLOGICAL REVIEWS, 2004, 84 (03) :869-901
[7]   Antiendothelial cell antibodies in vasculitis and connective tissue disease [J].
Belizna, C. ;
Duijvestijn, A. ;
Hamidou, M. ;
Tervaert, J. W. Cohen .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) :1545-1550
[8]   Apoptotic vascular endothelial cells become procoagulant [J].
Bombeli, T ;
Karsan, A ;
Tait, JF ;
Harlan, JM .
BLOOD, 1997, 89 (07) :2429-2442
[9]   TNF-mediated inflammatory disease [J].
Bradley, J. R. .
JOURNAL OF PATHOLOGY, 2008, 214 (02) :149-160
[10]  
BRADLEY JR, 1993, AM J PATHOL, V142, P1598